Hrt Financial LP Moderna, Inc. Transaction History

Hrt Financial LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$101.21 - $166.61 $5.5 Million - $9.06 Million	54,376 New	54,376 $6.46 Million
Q2 2023 Aug 11, 2023	SELL	$118.5 - $160.53 $9.65 Million - $13.1 Million	-81,460 Reduced 90.22%	8,833 $1.07 Million
Q1 2023 May 12, 2023	BUY	$135.66 - $197.02 $11.8 Million - $17.2 Million	87,201 Added 2820.21%	90,293 $13.9 Million
Q4 2022 Feb 10, 2023	BUY	$118.38 - $210.04 $366,030 - $649,443	3,092 New	3,092 $555,000
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $1.72 Million - $3.19 Million	-13,590 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $3.07 Million - $5.01 Million	13,590 New	13,590 $3.45 Million
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $132 Million - $289 Million	-596,019 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $75.6 Million - $137 Million	582,300 Added 4244.48%	596,019 $140 Million
Q1 2021 May 17, 2021	BUY	$109.18 - $185.98 $1.5 Million - $2.55 Million	13,719 New	13,719 $1.8 Million
Q4 2020 Feb 16, 2021	SELL	$65.74 - $169.86 $953,032 - $2.46 Million	-14,497 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$54.34 - $94.85 $787,766 - $1.38 Million	14,497 New	14,497 $1.03 Million

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.